Cassava Sciences, Inc. (SAVA) Tops Q3 EPS by 15c

Cassava Sciences, Inc. (NASDAQ: SAVA) reported Q3 EPS of ($0.58), $0.15 better than the analyst estimate of ($0.73).

For earnings history and earnings-related data on Cassava Sciences, Inc. (SAVA) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Candel Therapeutics Inc. (CADL) PT Raised to $15 at Freedom Broker
• Wolfpack Research: 'we are short FTK because their $400m deal has been canceled'